CMNIX
Price
$15.63
Change
-$0.00 (-0.00%)
Updated
Sep 15 closing price
Net Assets
16.77B
WMNUX
Price
$10.06
Change
+$0.02 (+0.20%)
Updated
Sep 15 closing price
Net Assets
127.71M
Interact to see
Advertisement

CMNIX vs WMNUX

Header iconCMNIX vs WMNUX Comparison
Open Charts CMNIX vs WMNUXBanner chart's image
Calamos Market Neutral Income I
Price$15.63
Change-$0.00 (-0.00%)
VolumeN/A
Net Assets16.77B
Westwood Alternative Income Ultra
Price$10.06
Change+$0.02 (+0.20%)
VolumeN/A
Net Assets127.71M
CMNIX vs WMNUX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
CMNIX vs. WMNUX commentary
Sep 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CMNIX is a Buy and WMNUX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CMNIX has more cash in the bank: 16.8B vs. WMNUX (128M). WMNUX pays higher dividends than CMNIX: WMNUX (3.03) vs CMNIX (1.89). CMNIX was incepted earlier than WMNUX: CMNIX (25 years) vs WMNUX (10 years). WMNUX (1.08) is less costly to investors than CMNIX (0.97). WMNUX is a more actively managed with annual turnover of: 51.00 vs. CMNIX (35.00). CMNIX (1000000) and WMNUX (1000000) have matching initial minimum investment requirements. WMNUX (7.31) and CMNIX (7.19) have marching annual gain over last year. WMNUX return over 5 years is better than : 24.82 vs. CMNIX (21.09).
CMNIXWMNUXCMNIX / WMNUX
Total Expense Ratio0.970.85114%
Annual Report Gross Expense Ratio0.971.0890%
Fund Existence25 years10 years-
Gain YTD5.1955.82389%
Front LoadN/AN/A-
Min. Initial Investment10000001000000100%
Min. Initial Investment IRAN/AN/A-
Net Assets16.8B128M13,125%
Annual Yield % from dividends1.893.0362%
Returns for 1 year7.197.3198%
Returns for 3 years19.4121.2491%
Returns for 5 years21.0924.8285%
Returns for 10 years39.6640.3898%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PHLCX12.38N/A
N/A
PGIM Jennison Health Sciences C
SUWCX34.32N/A
N/A
DWS Core Equity C
PUMYX15.04N/A
N/A
PACE Small/Medium Co Growth Equity Y
MSTGX10.00N/A
N/A
Morningstar Global Income
NUEIX23.26N/A
N/A
Northern US Quality ESG I